Grain-Sized Moxibustion Heightens the AntiTumor Effect of Cyclophosphamide in Hepa1-6 Bearing Mice

Figure 1

Schematic diagram of the experimental procedure and mouse acupoints. (a) Flowchart of experimental interventions. a. Cyclophosphamide (CTX), (b) Grain-sized moxibustion, c. Body weight, state score of survival, tumor volume, white blood cell (WBC). The Hepa1-6-bearing mice in the T and GT groups were treated with CTX on days 6, 7, and 8. The tumor-bearing mice in the G and the GT groups were treated with moxibustion on days 6–15 (once a day). The tumor volume, state of survival, and WBCs were measured on days 3, 6, 9, 12, and 15, and mice were sacrificed on day 16 for tissue collection. b. The location of acupoints (Dazhui DU14, Zusanli ST36, and Sanyinjiao SP6, red arrow) in Hepa1-6-bearing mice. c. Control group; g. grain-sized moxibustion group; T: CTX group, GT: grain-sized moxibustion plus CTX group.

(a)

(b)